NorthWest Biotherapeutics Inc (NWBO)

[pgsd]

"The question that I think we need to answer is why are 27 modules being prepared for submission. That seems excessive for one drug in one jurisdiction. I have read the previous theories but they remain speculative"

My own speculative take on this is that it might relate to the fact that the P3 trial was for nGBM however, as a result of the remarkable results for rGBM there is no way that the company will not include rGBM approval request also, just IMO.